Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...

Diseases of the joints are known as arthritis. The term is derived from the Greek word that means exactly that: diseases of ...

UCB, a global biopharmaceutical company, announced today that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of ...

Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...

Arthritis is a common condition characterized by joint pain and stiffness. It’s crucial to debunk myths about its causes, age ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

Psychological resilience plays an important role in managing psoriasis symptoms and enhancing patient well-being, study ...

Dependable recurring dividends from quality, high-yield stocks like these five are a recipe for passive income success.

A successful claim for PIP or ADP currently provides between £28.70 and £184.30 each week in additional financial support. As ...